Superficial bladder cancer in women is more treatable. Female superficial bladder cancer refers to non-muscle invasive bladder cancer, which is a more common type of bladder cancer, meaning that the tumor grows on the surface of the bladder wall and does not invade into the muscle layer of the bladder wall. Transurethral cystectomy is feasible, and combined radiotherapy or chemotherapy may be needed after the surgery, and partial cystectomy or radical cystectomy may be needed for some patients. Female superficial bladder cancer can also be treated with bladder instillation, which mainly involves the use of drugs such as BCG, mitomycin C, epirubicin, pirenzolibicin and other drugs for bladder instillation. The prognosis of female superficial bladder cancer has a great relationship with specific analysis as well as grading. Generally speaking, the higher the grading, the higher the chance of recurrence or progression of microscopic basal invasive bladder cancer, so it is recommended to receive treatment as early as possible, and to have regular rechecks and insist on long term follow up after surgery. All the above medications should be used under doctor’s guidance, avoid self-medication.